A CAGR of 6.53% is projected for the influenza vaccines market share by 2025, reaching USD 7,828.3 Million.  Humans are susceptible to the influenza virus, a very common and deadly virus that can infect their respiratory systems. A respiratory illness caused by a virus, influenza affects the lungs, nose, and throat.  Chronically ill people and those with weak immune systems...